Building Blocks

N-Methyl-4-phenylaniline (NMP) is a fatty acid inhibitor that can be used to treat hepatitis. It is an inhibitor of the enzyme known as N-hydroxy-4-aminobiphenyl amidohydrolase, which is involved in the second step of the synthesis of arachidonic acid, a precursor of prostaglandins. The inhibition of this enzyme reduces the production of prostaglandin E2 and other eicosanoids that are important for inflammation. NMP has also been shown to have potential mechanism for treating primary sclerosing cholangitis (PSC). This drug binds with bile salts in the intestines and prevents their reabsorption back into circulation. This leads to increased bile salt concentrations in the liver, which may help reduce inflammation and fibrosis in PSC.

1-Indanone oxime is a sulfonylating agent that reacts with primary amines to produce sulfonylureas. It is a model system for the study of chemical diversity and isozymes. 1-Indanone oxime has been shown to be an efficient synthetic agent for preparing hydroxyl compounds and oxime derivatives, and can be used to synthesize chlorides, secondary amines, and tertiary amines. The reaction time required for this chemical is shorter than other reagents such as sodium hypochlorite or nitrous acid. The reaction solution can be used in the synthesis of hydrochloric acid, nitric acid, chloroform, and vinyl chloride. 1-Indanone oxime has also been used to produce amino acids such as L-tryptophan or L-tyrosine.

N-Carbamoylmaleimide is a maleimide that reacts with amides to form N-hydroxysuccinimidyl esters. It is used as an alternative to succinimidyl esters for the synthesis of cross-linked polymers. The reaction proceeds via a cyclic intermediate, and is catalyzed by metal ions such as iron. The product is stable at room temperature, but decomposes at elevated temperatures. N-Carbamoylmaleimide can be synthesized by the reaction of methylbenzene with ammonia in the presence of sodium hydroxide, followed by dehydration with sulfuric acid. This compound can also be synthesized using a solid phase synthesis technique, which involves reacting an amine with vinyl ether and dimethylformamide in the presence of a carbonylating agent such as dicyclohexylcarbodiimide (DCC).

1-Chloroisoquinolin-4-ol is a phenylpyrimidine with anti-inflammatory properties. It is used in the treatment of sensitivity and mediated diseases, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 1-Chloroisoquinolin-4-ol inhibits the enzymatic activity of matrix metalloproteinases (MMPs), which are enzymes that break down collagen and other proteins in the body. The inhibition of MMPs by 1-chloroisoquinolin-4-ol leads to reduced inflammation and pain. This compound is also an effective inhibitor of the activities of chloride channels involved in acid secretion by cells in the stomach lining, thus inhibiting acid production. 1-Chloroisoquinolin-4-ol has been shown to have anticholesterolemic effects on liver cells due to its ability to inhibit cholesterol synthesis through inhibition of HMG CoA

Versatile small molecule scaffold

1-Phenylpentane-2,4-dione is a molecule that absorbs light. It has been shown to be an efficient absorber of solar radiation and has the potential to be used in photovoltaic devices. 1-Phenylpentane-2,4-dione can be used as an electron donor in polymer solar cells because it is able to act as both a chelate and a light absorber. 1-Phenylpentane-2,4-dione can also be used in acetone peroxide based solar cells because it is able to absorb light efficiently. In addition, 1-phenylpentane-2,4-dione may have use as an optical element for positioning systems such as telescopes or cameras.

N1-Cyclohexylpropane-1,3-diamine is a potent compound that has been shown to inhibit cholesterol synthesis and mitochondrial membrane potential. This drug also has anti-cancer effects and can be used for the treatment of cancers in which nuclear DNA is affected by light emission. N1-Cyclohexylpropane-1,3-diamine has been shown to have physiological activities such as cell growth inhibition, matrix effect, and intracellular hydrogen release. The drug binds to the enzyme activity site with a coordination geometry that is similar to other inhibitors of cholesterol synthesis. N1-Cyclohexylpropane-1,3-diamine was crystallized from methanol at room temperature and its molecular structure was determined by X-ray diffraction techniques.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold